logo
  

Altimmune Tanks 35% After It Discontinues Covid-19 Vaccine Development

Shares of Altimmune Inc. (ALT) plunged 35% in extended session on Tuesday after the clinical-stage biopharmaceutical company said that its stopping development of its investigational Covid-19 vaccine AdCOVID.

The company decided to discontinue AdCOVID's development after the intranasal vaccine candidate did not stimulate an adequate immune response in healthy volunteers.

"AdCOVID appeared to be well tolerated with an overall adverse event profile similar to intranasal saline placebo. The immunogenicity data demonstrated lower than expected immune responses for each of the immune parameters tested," the company said in a statement.

The company said that antibodies were detected in a subset of subjects, but the response and the percent of subjects responding to AdCOVID were substantially lower than what had been demonstrated for other vaccines already authorized for emergency use.

"The immune response to AdCOVID was inferior to that seen in our NasoVAX influenza vaccine trial," commented Scot Roberts, PhD, Chief Scientific Officer at Altimmune. "Unlike the NasoVAX study, the AdCOVID study population lacked immunity from prior infection or vaccination. We believe that prior immunity in humans may be important for a robust immune response to intranasal dosing with AdCOVID."

The company also decided to terminate further enrollment and evaluate options for future T-COVID development following an assessment of the available data.

ALT closed Tuesday's trading at $15.90, down $0.40 or 2.45%, on the Nasdaq. The stock, further slipped $5.72 or 35.97%, in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Velvet Ice Cream recalled certain lots of its 56 oz Raspberry Fudge Cordial Ice Cream for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was notified of the issue by a single customer and has since learned that the cause of the error has been traced to a third-party manufacturer packaging error. Willard, Ohio-based Buurma Farms Inc. is recalling 320 boxes of its Plain Parsley citing possible contamination with Shiga-toxin producing E.coli, the U.S. Food and Drug Administration said. The recall involves Buurma Plain (flat leaf) Parsley with a harvest date of August 30, 2021 from their Gregory, Michigan location. Molson Coors Beverage Co. is bringing Topo Chico Hard Seltzer, the sparkling mineral water, across the United States starting January 2022. The company will officially expand the distribution of the product, which was launched last spring in nine states and seven metro areas, to all 50 states. Molson Coors is manufacturing, marketing and distributing Topo Chico Hard Seltzer in the U.S.
RELATED NEWS
Follow RTT